title: Persistent major molecular response to nilotinib therapy in a patient with chronic myeloid leukemia harboring ABL gene T315I mutation.
authors.affiliation: a Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Key laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University , Suzhou , Jiangsu Province, 215006 , PR China.
authors.forename: Jinyi
authors.initials: J
authors.lastname: Zhou
authors.affiliation: a Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Key laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University , Suzhou , Jiangsu Province, 215006 , PR China.
authors.forename: Qi
authors.initials: Q
authors.lastname: Qu
authors.affiliation: a Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Key laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University , Suzhou , Jiangsu Province, 215006 , PR China.
authors.forename: Suning
authors.initials: S
authors.lastname: Chen
authors.affiliation: a Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Key laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University , Suzhou , Jiangsu Province, 215006 , PR China.
authors.forename: Yang
authors.initials: Y
authors.lastname: Xu
authors.affiliation: a Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Key laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University , Suzhou , Jiangsu Province, 215006 , PR China.
authors.forename: Hongjie
authors.initials: H
authors.lastname: Shen
authors.affiliation: a Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Key laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University , Suzhou , Jiangsu Province, 215006 , PR China.
authors.forename: Jiannong
authors.initials: J
authors.lastname: Cen
authors.affiliation: a Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Key laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University , Suzhou , Jiangsu Province, 215006 , PR China.
authors.forename: Depei
authors.initials: D
authors.lastname: Wu
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003062:Codon; D004252:DNA Mutational Analysis; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D015870:Gene Expression; D016313:Genes, abl; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D003062:Codon; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D016044:Fusion Proteins, bcr-abl; C498826:nilotinib